Stay updated with breaking news from Technology Analytics Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IQVIA (NYSE:IQV – Free Report) had its target price lowered by Guggenheim from $253.00 to $220.00 in a research note released on Friday, Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities research analysts have also commented on IQV. Mizuho decreased their price target on IQVIA […]
IQVIA (NYSE:IQV – Get Free Report) had its target price reduced by equities research analysts at Morgan Stanley from $240.00 to $225.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Morgan Stanley’s target price indicates a potential upside of […]
IQVIA (NYSE:IQV – Get Free Report) had its price target dropped by stock analysts at Truist Financial from $260.00 to $240.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Truist Financial’s price objective points to a potential upside of 25.98% from […]
IQVIA (NYSE:IQV – Get Free Report) had its price target lowered by Truist Financial from $260.00 to $240.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Truist Financial’s price objective points to a potential upside of 25.98% from the stock’s current price. […]
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA's Third Quarter 2023 Earnings Conference Call. [Operator Instructions].